Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Brainstorm Cell Therapeutics Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 52
- −5 vs. Q2 2021
- Shares held
- 5.13M
- −495.4K (−8.8%) vs. Q2 2021
- Total value
- $16.9M
- −$4.46M (−20.8%) vs. Q2 2021
- New holders
- 5
- 8 more added
- Sold out
- 10
- 25 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCLI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 5 | $1.73K |
| Q2 2025 | 34 | $264.0K |
| Q1 2025 | 32 | $1.09M |
| Q4 2024 | 34 | $560.3K |
| Q3 2024 | 38 | $2.52M |
| Q2 2024 | 48 | $4.09M |
| Q1 2024 | 47 | $2.19M |
| Q4 2023 | 46 | $1.04M |
| Q3 2023 | 53 | $928.4K |
| Q2 2023 | 57 | $11.5M |
| Q1 2023 | 48 | $20.4M |
| Q4 2022 | 43 | $6.16M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 48 | $11.0M |
| Q1 2022 | 39 | $14.0M |
| Q4 2021 | 42 | $17.6M |
| Q3 2021 | 52 | $16.9M |
| Q2 2021 | 57 | $21.4M |
| Q1 2021 | 75 | $32.1M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Brainstorm Cell Therapeutics Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,432,419 | $4.73M | 0.00% | +19,593+1.4% | Added |
| Sabby Management, LLC | 476,325 | $1.57M | 0.34% | +233,475+96.1% | Added |
| BlackRock Inc. | 468,967 | $1.55M | 0.00% | −5,380−1.1% | Reduced |
| JPMorgan Chase & Co | 445,698 | $1.47M | 0.00% | −252,596−36.2% | Reduced |
| Ikarian Capital, LLC | 289,550 | $955.0K | 0.22% | −3,650−1.2% | Reduced |
| Geode Capital Management, LLC | 275,750 | $909.0K | 0.00% | +10,612+4.0% | Added |
| Abner Herrman & Brock LLC | 205,000 | $676.0K | 0.10% | −36,500−15.1% | Reduced |
| Raymond James & Associates | 199,768 | $659.0K | 0.00% | +250.0% | Added |
| Gsa Capital Partners LLP | 172,056 | $568.0K | 0.06% | +111,818+185.6% | Added |
| Millennium Management LLC | 150,327 | $496.0K | 0.00% | −221,133−59.5% | Reduced |
| Ergoteles LLC | 122,667 | $405.0K | 0.01% | −1,662−1.3% | Reduced |
| Pura Vida Investments, LLC | 106,834 | $353.0K | 0.03% | +106,834 | New |
| Price T Rowe Associates Inc | 93,000 | $307.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 86,703 | $286.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 81,489 | $268.0K | 0.00% | −4,508−5.2% | Reduced |
| Northern Trust Corp | 59,091 | $195.0K | 0.00% | +9,330+18.7% | Added |
| Morgan Stanley | 52,514 | $174.0K | 0.00% | −1,171−2.2% | Reduced |
| Weaver Consulting Group | 51,500 | $170.0K | 0.09% | +2,619+5.4% | Added |
| Susquehanna International Group, LLP | 39,031 | $129.0K | 0.00% | +39,031 | New |
| Acadian Asset Management LLC | 35,893 | $118.0K | 0.00% | −103,440−74.2% | Reduced |
| Boothbay Fund Management, LLC | 29,186 | $96.0K | 0.00% | −3,650−11.1% | Reduced |
| Goldman Sachs Group Inc | 17,600 | $58.0K | 0.00% | −40,079−69.5% | Reduced |
| Steward Partners Investment Advisory, LLC | 17,000 | $56.0K | 0.00% | −2,000−10.5% | Reduced |
| HighPoint Advisor Group LLC | 17,033 | $56.0K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 16,480 | $54.0K | 0.00% | −34,687−67.8% | Reduced |
| Aptus Capital Advisors, LLC | 16,000 | $53.0K | 0.00% | −2,350−12.8% | Reduced |
| Two Sigma Investments, LP | 15,900 | $52.0K | 0.00% | −32,142−66.9% | Reduced |
| Bank of New York Mellon Corp | 15,899 | $52.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 13,182 | $44.0K | 0.00% | +376+2.9% | Added |
| Raymond James Financial Services Advisors, Inc. | 12,731 | $42.0K | 0.00% | −250−1.9% | Reduced |
| CFO4Life Group, LLC | 12,000 | $40.0K | 0.01% | −30.0% | Reduced |
| Bank of America Corp | 11,727 | $38.0K | 0.00% | −24,589−67.7% | Reduced |
| Charles Schwab Investment Management Inc | 11,287 | $38.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 11,008 | $37.0K | 0.00% | −3,000−21.4% | Reduced |
| Advisor Group Holdings, Inc. | 10,920 | $37.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 10,700 | $35.0K | 0.00% | −9,000−45.7% | Reduced |
| Walleye Capital LLC | 10,639 | $35.0K | 0.00% | +10,639 | New |
| Occudo Quantitative Strategies LP | 10,168 | $34.0K | 0.00% | +10,168 | New |
| Harbour Investments, Inc. | 8,269 | $27.0K | 0.00% | −1,175−12.4% | Reduced |
| Barclays PLC | 4,267 | $14.0K | 0.00% | −3,721−46.6% | Reduced |
| Bank Julius Baer & Co. Ltd, Zurich | 4,167 | $14.0K | 0.00% | −44−1.0% | Reduced |
| Institutional & Family Asset Management, LLC | 3,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| Washington Trust Co | 2,500 | $8.00K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 2,100 | $7.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,533 | $5.00K | 0.00% | −339−18.1% | Reduced |
| Brewin Dolphin Ltd | 700 | $2.31K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 666 | $2.00K | 0.00% | +666 | New |
| BNP Paribas Arbitrage, SA | 481 | $1.59K | 0.00% | −1,421−74.7% | Reduced |
| First Manhattan Co | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Mark Sheptoff Financial Planning, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −87,000−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −74,691−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −47,600−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,543−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −12,696−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −11,800−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −11,735−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −2,750−100.0% | Sold out |
| Cypress Capital Management LLC (WY) | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −273−100.0% | Sold out |